Posted by Michael Wonder on 30 Mar 2022
Pfizer’s oral COVID-19 treatment arrives in New Zealand
31 March 2022 - The first shipment of Pfizer’s new oral antiviral treatment for COVID-19, Paxlovid, has arrived in New Zealand and will be available for those who need it from next week.
“While vaccinations and booster shots are the best defence against COVID-19, having more treatments is important for those who become unwell and need further treatment.” says PHARMAC’s Chief Executive Sarah Fitt.
“The agreement for Paxlovid was that the first batch would be delivered between April and June 2022, so we are especially pleased at how quickly New Zealand has been able receive the treatment,” says Sarah.
